Submit Deal

SHIRE PLC

Summary

Shire is a Jersey-registered specialty biopharmaceutical company. Shire is focused on serving people with rare diseases and other highly specialized conditions.

Deals Overview

Total Deals8

Valued Deals7

Total Value£ 102.78 B

Avg. Deal Size£ 14.68 B

Market Context

Subsidiaries

SHIRE PLC ONCOLOGY BUSINESS

1 transaction

Senior Management

Flemming Ornskov
CEO
Thomas Dittrich
CFO
Susan Kilsby
Chairman

Sort

slaughter & may

HQ - London, United Kingdom

legal advisors (5)

5 Shared Deals

5 For

£ 100.74 B

Total Value

davis polk & wardwell

HQ - New York

legal advisors (6)

6 Shared Deals

6 For

£ 82.12 B

Total Value

deutsche bank

HQ - Frankfurt

brokers (1)

financial advisors (2)

3 Shared Deals

3 For

£ 56.38 B

Total Value

morgan stanley

HQ - New York

brokers (2)

financial advisors (5)

7 Shared Deals

7 For

£ 178.82 B

Total Value

goldman sachs

HQ - New York

financial advisors (5)

5 Shared Deals

3 For | 2 Opposite

£ 98.58 B

Total Value

evercore

HQ - New York

financial advisors (4)

4 Shared Deals

3 For | 1 Opposite

£ 100.74 B

Total Value

citigroup

HQ - New York

financial advisors (4)

brokers (1)

5 Shared Deals

4 For | 1 Opposite

£ 141.25 B

Total Value

jp morgan

HQ - New York

financial advisors (2)

debt providers (1)

3 Shared Deals

3 Opposite

£ 120.75 B

Total Value

herbert smith freehills

HQ - London

legal advisors (1)

1 Shared Deal

1 Opposite

£ 32.05 B

Total Value

sullivan & cromwell

HQ - New York

legal advisors (3)

3 Shared Deals

3 Opposite

£ 80.24 B

Total Value

latham & watkins

HQ - New York, United States

legal advisors (3)

3 Shared Deals

3 Opposite

£ 48.35 B

Total Value

skadden arps slate meagher & flom

HQ - New York

legal advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy